Astellas Pharma Inc.
Símbolo: ALPMF
PNK
10.035
USDPrecio de mercado actual
216.5947
Ratio PER
0.4210
Ratio PEG
17.99B
Capitalización MRK
- 0.00%
Rendimiento DIV
Astellas Pharma Inc. (ALPMF) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1587585 | 335687 | 396624 | 337283 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 102440 | 0 | 19784 | 21297 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 2039347 | 548036 | 446516 | 404001 | |||||||||||||||||||||
balance-sheet.row.inventory | 888590 | 248738 | 174386 | 153072 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 163520 | 62269 | 32428 | 28998 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 4679042 | 1194730 | 1049954 | 923354 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1170110 | 293742 | 286459 | 269044 | |||||||||||||||||||||
balance-sheet.row.goodwill | 1566168 | 418694 | 328411 | 303030 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 5029140 | 1453824 | 562496 | 623431 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 6595308 | 1872518 | 890907 | 926461 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 462124 | 144421 | 145028 | 141206 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 233139 | 45594 | 84169 | 72331 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 139541 | 18598 | 1 | -1 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 8600222 | 2374873 | 1406564 | 1409041 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 13279264 | 3569603 | 2456518 | 2332395 | |||||||||||||||||||||
balance-sheet.row.account-payables | 621308 | 185193 | 140236 | 130739 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1605013 | 472278 | 88546 | 157730 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 120932 | 38515 | 5137 | 32388 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1434596 | 447738 | 54217 | 676 | |||||||||||||||||||||
Deferred Revenue Non Current | 398707 | 0 | 121279 | 138943 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 220571 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 1902520 | 589739 | 585798 | 556672 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2369066 | 687890 | 222530 | 184676 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 200484 | 0 | 61461 | 55014 | |||||||||||||||||||||
balance-sheet.row.total-liab | 6962259 | 1973615 | 948564 | 872087 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 1133697 | 0 | 1167315 | 1212796 | |||||||||||||||||||||
balance-sheet.row.common-stock | 412004 | 103001 | 103001 | 103001 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 3417069 | 809400 | 908158 | 944261 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1880296 | 518678 | 340639 | 247512 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -526061 | 164909 | -1011159 | -1047262 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 6317005 | 1595988 | 1507954 | 1460308 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 13279264 | 3569603 | 2456518 | 2332395 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 6317005 | 1595988 | 1507954 | 1460308 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 13279264 | - | - | - | |||||||||||||||||||||
Total Investments | 490761 | 144421 | 110575 | 101879 | |||||||||||||||||||||
balance-sheet.row.total-debt | 3039609 | 920016 | 200007 | 212744 | |||||||||||||||||||||
balance-sheet.row.net-debt | 1554464 | 584329 | -176833 | -103242 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 40352 | 17045 | 132361 | 156886 | |||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 157840 | 157840 | 105738 | 79684 | |||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.change-in-working-capital | -68238 | -51702 | -24209 | 5956 | |||||||||||||||||||||
cash-flows.row.account-receivables | -55948 | -55948 | -4849 | -8001 | |||||||||||||||||||||
cash-flows.row.inventory | -60036 | -60036 | -7086 | 24058 | |||||||||||||||||||||
cash-flows.row.account-payables | 29466 | 29466 | -12274 | -10101 | |||||||||||||||||||||
cash-flows.row.other-working-capital | 34816 | 34816 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.other-non-cash-items | 138353 | 460340 | 113877 | 14918 | |||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 175050 | 0 | 0 | 0 | |||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -82497 | -82497 | -88541 | -76448 | |||||||||||||||||||||
cash-flows.row.acquisitions-net | -784974 | -784974 | 0 | -670 | |||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -5576 | |||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 12624 | 5576 | |||||||||||||||||||||
cash-flows.row.other-investing-activites | 19094 | 12819 | -8583 | 14705 | |||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -848377 | -854652 | -84500 | -62413 | |||||||||||||||||||||
cash-flows.row.debt-repayment | -805689 | -771233 | -50000 | -60000 | |||||||||||||||||||||
cash-flows.row.common-stock-issued | -216772 | 0 | 18505 | -17815 | |||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -10735 | -10735 | -60556 | -50717 | |||||||||||||||||||||
cash-flows.row.dividends-paid | -116653 | -116653 | -100355 | -85236 | |||||||||||||||||||||
cash-flows.row.other-financing-activites | 1680968 | -16539 | -3217 | -2530 | |||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 614060 | 614060 | -195623 | -216298 | |||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 18113 | 18113 | 13210 | 11125 | |||||||||||||||||||||
cash-flows.row.net-change-in-cash | -41153 | -41153 | 60854 | -10142 | |||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1485145 | 335687 | 376840 | 315986 | |||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1526298 | 376840 | 315986 | 326128 | |||||||||||||||||||||
cash-flows.row.operating-cash-flow | 175050 | 181325 | 327767 | 257444 | |||||||||||||||||||||
cash-flows.row.capital-expenditure | -82497 | -82497 | -88541 | -76448 | |||||||||||||||||||||
cash-flows.row.free-cash-flow | 92553 | 98828 | 239226 | 180996 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1603671 | 1603672 | 1518619 | 1296163 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 325131 | 391305 | 288353 | 253009 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 1278540 | 1212367 | 1230266 | 1043154 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 294187 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 546961 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 1180111 | 1034297 | 1098709 | 912191 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1505242 | 1425602 | 1387062 | 1165200 | |||||||||||||||||||||
income-statement-row.row.interest-income | 11454 | 11455 | 8110 | 6149 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 12005 | 12005 | 8779 | 4949 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -83431 | -149936 | -99291 | -61259 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -83431 | -149936 | -99291 | -61259 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 12005 | 12005 | 8779 | 4949 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 157840 | 157840 | 105738 | 79684 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | 263138 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | 107704 | 178070 | 133029 | 155686 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | 23534 | 28134 | 132361 | 156886 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7924 | 7924 | 33647 | 32800 | |||||||||||||||||||||
income-statement-row.row.net-income | 12905 | 17045 | 98714 | 124086 |
Preguntas frecuentes
Cuánto es Astellas Pharma Inc. (ALPMF) activos totales?
Astellas Pharma Inc. (ALPMF) los activos totales son 3569603000000.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 836534000000.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.797.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 51.622.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.008.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.067.
¿Qué es Astellas Pharma Inc. (ALPMF) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 17045000000.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 920016000000.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 1034297000000.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 335687000000.000.